Secondary Metabolites

Secondary metabolites are compounds that a plant produces beyond the core machinery of growth and reproduction — they are not required for basic survival of every cell but mediate the plant's interaction with its environment, in defence, signalling, and protection. Many of them are the pharmacologically active constituents that make plants a source of medicines.

Definition

Secondary metabolites are organic compounds produced by plants that are not directly involved in normal growth, development, or reproduction, but typically serve ecological roles and frequently possess biological activity of pharmaceutical interest.

Scope

This topic covers the concept of secondary (specialised) metabolism in plants, how it differs from primary metabolism, the biosynthetic origins that organise the major compound classes, and why these molecules are central to natural-product pharmacognosy. It is reference material on plant chemistry, not clinical guidance.

Core questions

• What distinguishes secondary from primary metabolism?
• From which biosynthetic pathways do the main classes of secondary metabolites arise?
• Why are secondary metabolites disproportionately important as drug leads?

Key concepts

• Primary versus secondary metabolism
• Ecological and defensive roles
• Constitutive versus induced production
• Shikimate, mevalonate, MEP, and polyketide pathways
• Chemical diversity from shared precursors
• Chemotaxonomy

Mechanisms

Secondary metabolites are built from intermediates of primary metabolism — acetyl-CoA, aromatic amino acids, and isoprenoid units — that are diverted into dedicated pathways. The shikimate pathway feeds phenolics and many alkaloids, the mevalonate and methylerythritol-phosphate pathways feed terpenoids, and amino acids seed most alkaloid skeletons. Enzymatic elaboration, oxidation, and conjugation then generate the wide structural diversity that characterises the class. Production is often regulated developmentally and induced by stress or attack, consistent with ecological roles in defence and signalling.

Clinical relevance

Because so many drugs are secondary metabolites or derivatives of them, this class is the principal reservoir from which natural-product pharmacology draws. The entry explains why plant chemistry yields medicinally active molecules; it is descriptive and not a basis for diagnosis, dosing, or treatment decisions.

Evidence & guidelines

Evidence here is chemical and biosynthetic — isolation studies, pathway elucidation, and reviews of natural products as drug sources — rather than clinical-trial evidence. Reviews documenting the contribution of natural products to approved drugs summarise the field's practical importance.

History

The recognition that plants make compounds beyond those needed for growth crystallised in the twentieth century as biosynthetic study mapped the pathways linking primary intermediates to specialised products. The framing of these compounds as ecologically functional, rather than metabolic waste, reshaped how their diversity and pharmacological value were understood.

Seminal works

• newman-2007
• dewick-2009

Frequently asked questions

Why are they called 'secondary' metabolites?

The term distinguishes them from primary metabolites essential to basic cellular life; secondary metabolites are not required for survival of every cell but serve specialised, often ecological, functions.

Are secondary metabolites the same as natural products?

In pharmacognosy the terms overlap heavily: most plant 'natural products' of pharmaceutical interest are secondary metabolites, though the broader natural-products field also includes compounds from microbes and other organisms.